spacer
spacer
portal Chinese Intro
spacer



spacer Life Science News

EU adopts new biosimilar guideline

Author: Liz Jones Hollis
Source: FierceBiotech (Read full article)
Date: 2010-11-19

European regulators have adopted a guideline on biosimilar antibody drugs; industry can expect its publication in a couple of weeks. However, many experts already anticipate a cautious approach, requiring separate clinical trials for different diseases addressed by the same antibody, as Reuters notes. In a release, the EMA briefly touched on the guidelines, titled 'Similar Biological Medicinal Pro .... More

Will China Lose Its Cost- Competitiveness In Pharma Manufacturing By 2015?

Author: Vishal Bhandari, Axel Erhard, and Saurabh Tejwani of A.T. Kearney
Source: Life Science Leader (Read full article)
Date: 2010-09-07

With rising cost pressure, Western pharmaceutical companies have aggressively sought low-cost country sources for pharmaceutical manufacturing over the last few years, fueling the growth for the Chinese pharmaceutical industry. Exports from Chinese pharmaceutical companies grew at double-digit rates over the last few years and were close to $30 billion in 2009. Pharmaceutical firms have contin .... More

VC life science investing skyrockets in Bay Area, nationally Read more: VC life science investing

Author: Ron Leuty
Source: San Francisco Business Times (Read full article)
Date: 2010-08-05

Second-quarter life sciences investing in the Bay Area rose 175 percent from the first three months of the year, according to PricewaterhouseCoopers LLP. Overall, life sciences investing in the first half of this year hit $3.4 billion - including a $2.1 billion rebound in the second quarter - an increase of 26 percent from a low base of the same six months of last year, according to a report re .... More

The Next Blockbuster Drugs: A $170 Billion Opportunity

Author: Mike Tarsala
Source: BioHealthInvestor.com (Read full article)
Date: 2010-07-22

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help from Thomson Pharma and our own backlog of coverage, BioHealthInvestor.com, a 247wallst.com website, sought to find the most promising biopharmaceutical candidate from both biotech and pharma .... More

Venture capital investments rise 53 percent

Author: Rachel Metz
Source: ASSOCIATED PRESS (Read full article)
Date: 2010-07-18

SAN FRANCISCO - Venture capitalists funneled more money into U. S. startups in the second quarter, indicating continuing confidence that the economy is on the mend. A study relased Friday shows that startup investments in the April-June period climbed 53 percent from the same three months in 2009 to $6.5 billion. This is the most money invested in startups since the third quarter of 2008. .... More

Drugmakers Prodded by FDA for Neglected Disease Drugs

Author: Catherine Larkin
Source: Bloomberg BusinessWeek (Read full article)
Date: 2010-06-18

Roche Holding AG, Johnson & Johnson and Biogen Idec Inc. are being urged by U.S. regulators to see if existing medicines may help neglected disorders, after an incentive program failed to spark research on new therapies. The Food and Drug Administration published a list of 235 treatments today that may have benefit in rare disorders and already have marketing clearance for other uses. Identifyi .... More

Survey Puts 2009 Asia-Pacific Life Science Revenues At $111 Billion

Author: China Bio Today
Source: istockanalyst (Read full article)
Date: 2010-06-17

BioSpectrum has released the 2010 Asia Pacific Survey of the life science industry. With the general warning that the survey was limited to publicly listed companies, BioSpectrum announced that Asia Pacific's life science industry grew 3.4% in 2009, producing total revenues of $111 billion. China was the biggest contributor, with a 32% share. The following are other headline statistics from it .... More

OPINION: Three Ways to Create a More Sustainable Future for Biotechnology

Author: Gail Maderis, President & CEO of BayBio
Source: Xconomy.com (Read full article)
Date: 2010-06-16

1.Encourage tax incentives and policies that would create more investment in biotech. We should create a tax holiday to allow repatriation of offshore profits that are used to fund R&D in small companies. There are huge profits that are locked up overseas and will never come back unless we provide a means for them to come back at attractive rates. The tax holiday could be limited to repatriated pr .... More

How the Recession Fueled San Diego Biotech Innovation

Author: CLAIRE TRAGESER
Source: voiceofsandiego.org (Read full article)
Date: 2010-06-15

Squaring his shoulders, Sridhar Prasad began to make his pitch in front of a crowd of 130 biotech professionals. He had 30 seconds to make a big impression to potential collaborators about his small startup company. In a soft voice, he explained how he uses new methods to search for potential medicines and hoped his mild-mannered pitch would convince the scientists and biotech executives in the .... More

Advances Come in War on Cancer

Author: RON WINSLOW And PETER LOFTUS
Source: The Wall Street Journal (Read full article)
Date: 2010-06-07

CHICAGO - Researchers reported notable advances in the war on cancer over the weekend, including treatments for lung, ovarian and skin cancers, but they cautioned that the disease continues to throw up daunting obstacles of cost and complexity. New data presented at a major cancer conference provided both practice-changing information on the use of current treatments and powerful evidence of th .... More

Melanoma drug a seismic shift in cancer

Author: Robert Bazell
Source: MSNBC (Read full article)
Date: 2010-06-05

Progress in cancer treatment usually creeps forward. While more people are living longer with more kinds of cancer than ever, the better treatments are often incremental improvements. But every five or 10 years a new medication arrives that totally shifts the paradigm, allowing thousands to live who would have otherwise died. Researchers today set off such a seismic shift for the treatment of a .... More

HK researchers discover new drug to treat flu

Source: Xinhua Net (Read full article)
Date: 2010-05-31

The University of Hong Kong Monday announced that their researchers have found that an important viral structural protein, influenza nucleoprotein, can be used as a target to kill influenza virus including H1N1, H3N2 and H5N1. According to the university, influenza nucleoprotein is an important influenza virus protein that has many important functions, from leading the viral genome into the cel .... More

10 comprehensive breakthroughs in biofuel production

Source: www.ecofriend.org (Read full article)
Date: 2010-05-31

With fossil fuels depleting fast, research work has been escalated to find new sources of fuel that are green as well. The answers aren't that difficult to find as several crops have the potential to produce fuel similar to diesel, which can easily replace conventional sources. However, since the demand for biofuel has increased, producing fuel from food crops isn't viable. Several universities an .... More

Biotech Firms May Get Up to $5 Million Tax Credit

Author: Drew Armstrong
Source: Bloomberg Businessweek (Read full article)
Date: 2010-05-21

As many as four million small businesses in the U.S. may qualify for tax credits to recover more than a third of the cost of providing medical care for employees, under a program created by the health overhaul law. Businesses with less than 25 full-time employees each will be eligible, according to a U.S. Treasury Department fact sheet made public today. Enterprises that qualify will get 35 perc .... More

Researchers Say They Created a Synthetic Cell

Author: NICHOLAS WADE
Source: New York Times (Read full article)
Date: 2010-05-20

The genome pioneer J. Craig Venter has taken another step in his quest to create synthetic life, by synthesizing an entire bacterial genome and using it to take over a cell.

Biotechnology to Expand Use of Biomass In China

Author: Joanna Schroeder
Source: Domesticfuel.com (Read full article)
Date: 2010-05-11

Novozymes continues to lead the way in biomass technologies with their new announcement that they are partnering with Dacheng Group, a major starch processing company based in China, to develop technologies designed to produce household cleaning products and plastics from agricultural waste. Both plastics and cleaning products typically have petroleum as one of their ingredients.

Pharma and biotech: is there love?

Author: David Ewing Duncan
Source: Fortune (Read full article)
Date: 2010-05-10

For at least a decade, anyone following the life sciences industry has noticed two naked truths. One is that the biggest pharmaceutical companies are struggling to replenish research development pipelines as their billion-dollar blockbuster drugs go off patent and in-house programs falter, all despite having spent billions on research and development.

Life Sciences Dominate at Wharton Competition

Author: LORA KOLODNY
Source: New York Times (Read full article)
Date: 2010-04-30

The Wharton School of the University of Pennsylvania held its 12th annual business plan competition on Wednesday. Eight finalists were selected from the 231 teams that applied. Cortical Concepts took the grand prize of $20,000 cash, and $10,000 worth of in-kind accounting and legal services, for its plan to sell a device that would make spine surgery safer for patients with osteoporosis or wea .... More

Charles River Buys Chinese Drug Research Firm

Author: DAVID BARBOZA and MICHAEL J. DE LA MERCED
Source: New York Times (Read full article)
Date: 2010-04-26

Charles River Laboratories said Monday that it had agreed to acquire WuXi Pharma Tech, a Chinese pharmaceutical outsourcing services provider, in a cash and stock deal worth $1.6 billion.

Venture-cap investments rise in 1Q, as optimism up

Author: RACHEL METZ AP Technology Writer
Source: San Jose Mercury News (Read full article)
Date: 2010-04-15

Venture capitalists invested more money in U.S. startups during the first three months of 2010 compared with a year earlier, a sign of increasing optimism that the economy is improving. Last year, the sluggish economy made it harder for startups to find buyers or complete initial public offerings. That meant venture capitalists had a harder time seeing returns on their investments, so they had b .... More

Big deals reshape Bay Area biotech industry

Author: null
Source: San Jose Mercury News (Read full article)
Date: 2010-03-12

A wave of multibillion-dollar deals this week signals the acceleration of a deal-making frenzy that will likely reshape the life-sciences industry. In the two latest, South San Francisco-based Genentech Thursday finally agreed to a $46.8 billion deal with Roche, while Foster City-based Gilead Sciences moved the same day to snap up Palo Alto-based CV Therapeutics for $1.4 billion. Earlier this .... More

Firms Prepare for a Fight Over Generic Drugs

Date: 2010-03-12

From Wall Street Journal, Mar 12, 2009
By Alicia Mundy

Biotechnology companies are gearing up for battle on Capitol Hill after Rep. Henry Waxman, the powerful California Democrat, introduced a bill that would clear a regulatory path for generic drug makers to produce copies of biologic medicines.

Companies such as Amgen Inc. and Genentech Inc. have fought off such efforts in the .... More


Stay Ahead of the Technology Curve

Source: Pharmaceutical Executive (Read full article)
Date: 2010-03-01

We live in the digital age, where information is abundantly available at a keystroke. Many industries have adapted to the revolution in information technology, but the healthcare industry still relies to a substantial extent on data capture and analysis methods that are outmoded or hobbled by proprietary formats that inhibit connectivity among data sources and technology platforms.

spacer
footer1footer